Cargando…

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production

This study investigated the anticancer effects of N-farnesyloxy-norcantharimide (NOC15), a newly synthesized norcantharidin (NCTD) analogue, on human leukemic Jurkat T cells and the signaling pathway underlying its effects. We found that the half maximal inhibitory concentration (IC50) of NOC15 on J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ming-Che, Wu, Jin-Yi, Liao, Hui-Fen, Chen, Yu-Jen, Kuo, Cheng-Deng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Preclinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588604/ https://www.ncbi.nlm.nih.gov/pubmed/26288134 http://dx.doi.org/10.1097/CAD.0000000000000284

Ejemplares similares

Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study
por: Chang, Ming-Che, et al.
Publicado: (2016)

Synthesis of Novel Lipophilic N-Substituted Norcantharimide Derivatives and Evaluation of Their Anticancer Activities
por: Wu, Jin-Yi, et al.
Publicado: (2014)

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
por: Ahmad, Dena A. J., et al.
Publicado: (2016)

Effects of pentachlorophenol and tetrachlorohydroquinone on mitogen-activated protein kinase pathways in Jurkat T cells.
por: Wispriyono, Bambang, et al.
Publicado: (2002)

Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
por: Nordlohne, Johannes, et al.
Publicado: (2018)

Associations of Interleukin-5 With Plaque Development and Cardiovascular Events
por: Knutsson, Anki, et al.
Publicado: (2019)

Effects of in vitro Brevetoxin Exposure on Apoptosis and Cellular Metabolism in a Leukemic T Cell Line (Jurkat)
por: Walsh, Catherine J., et al.
Publicado: (2008)

Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
por: Saleh, Mohamed A., et al.
Publicado: (2016)

ArtinM Mediates Murine T Cell Activation and Induces Cell Death in Jurkat Human Leukemic T Cells
por: da Silva, Thiago Aparecido, et al.
Publicado: (2017)

Interleukin-1β, Oxidative Stress, and Abnormal Calcium Handling Mediate Diabetic Arrhythmic Risk
por: Liu, Hong, et al.
Publicado: (2021)

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
por: George, Marc Jonathan, et al.
Publicado: (2021)

Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers
por: Savva, Constantinos, et al.
Publicado: (2019)

Location-specific and Kinase-Independent GRK5 Function in Heart
por: Wang, Yifan F., et al.
Publicado: (2022)

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models
por: Capasso, Anna, et al.
Publicado: (2018)

Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
por: Tahiri, Andliena, et al.
Publicado: (2020)

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
por: Alshaker, Heba, et al.
Publicado: (2018)

A Role for Polo-Like Kinase 4 in Vascular Fibroblast Cell-Type Transition
por: Li, Jing, et al.
Publicado: (2021)

With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2021)

Central carbon metabolism in the progression of mammary carcinoma
por: Richardson, Adam D., et al.
Publicado: (2007)

Pleiotropic Effects of Pyruvate Kinase M2 in Right Ventricular Failure and Pulmonary Arterial Hypertension
por: Christou, Helen
Publicado: (2022)

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
por: He, Jichao, et al.
Publicado: (2019)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Evaluation of skin sensitization based on interleukin-2 promoter activation in Jurkat cells
por: Nagahata, Taichi, et al.
Publicado: (2022)

Polysaccharide Isolated from Zizyphus jujuba (紅棗 Hóng Zǎo) Inhibits Interleukin-2 Production in Jurkat T Cells
por: Hsu, Bo-Yang, et al.
Publicado: (2014)

Differential Activity of Voltage- and Ca(2+)-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case
por: Valle-Reyes, Salvador, et al.
Publicado: (2018)

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
por: Al-Subhi, Nouf, et al.
Publicado: (2018)

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
por: Korobeynikov, Vladislav, et al.
Publicado: (2019)

Changes in Myocardial Microstructure and Mechanics With Progressive Left Ventricular Pressure Overload
por: Torres, William M., et al.
Publicado: (2020)

Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases
por: Yan, Yuan, et al.
Publicado: (2015)

Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
por: Özenver, Nadire, et al.
Publicado: (2020)

Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction
por: Sharp, Thomas E., et al.
Publicado: (2017)

MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping
por: Yan, S. Betty, et al.
Publicado: (2017)

Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice
por: Ueda, Hiromichi, et al.
Publicado: (2019)

Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits
por: Chowdhury, Mohammed M., et al.
Publicado: (2020)

The Role of E3 Ubiquitin Ligase Cbl Proteins in Interleukin-2-Induced Jurkat T-Cell Activation
por: Zhao, Ming-Fang, et al.
Publicado: (2013)

Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2
por: Goyeneche, Alicia A., et al.
Publicado: (2011)

N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
por: Mackey, John R., et al.
Publicado: (2021)

Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
por: Shim, Jeong, et al.
Publicado: (2017)

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
por: Yan, S. Betty, et al.
Publicado: (2012)

Circ-ABCC4 contributes to prostate cancer progression and radioresistance by mediating miR-1253/SOX4 cascade
por: Yu, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eodtsptrqjqoj7ngm4h7391tn7